Print Page

被 發 現 含 有 未 標 示 西 藥 的 產 品

 
Australia: JOYSMI capsules pose a serious risk to health and should not be taken (English Only)
 
The Therapeutic Goods Administration (TGA) has tested a product labelled JOYSMI capsules and found that the capsules contain the undeclared substances sibutramine, phenolphthalein and frusemide. Consumers are advised that in Australia sibutramine is a prescription-only substance (which was the active ingredient in Reductil). It was withdrawn in Oct 2010 after a study showed an increased risk of major cardiac events. Phenolphthalein is a prescription-only substance previously marketed as an oral laxative, withdrawn from sale in the late 1990’s due to concerns over its carcinogenicity with long term use. Frusemide is a prescription-only substance used for the treatment of oedema and high blood pressure.

Consumers are advised to stop taking the product and take any remaining capsules to their local pharmacy for safe disposal. If they have any concerns arising from their use of this product, consult their health care practitioner.

Please refer to the following website in TGA for details: http://www.tga.gov.au/alert/joysmi-capsules

In Hong Kong, the above product is not a registered pharmaceutical product.

Ends/Thursday, Apr 4, 2019
Issued at HKT 15:00
 
 
back